Paritaprevir
Back to searchMolecule Structure
Scientific Name
Paritaprevir
Description of the Drug
Paritaprevir is a direct acting antiviral agent used in combination with other antiviral agents for the treatment of Hepatitis C Virus (HCV) infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09297
http://www.drugbank.ca/drugs/DB09297
Brand Name(s)
Not Available
Company Owner(s)
Abbvie Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Hepatitis C virus serine protease, NS3/NS4A | PROTEIN COMPLEX | INHIBITOR | CHEMBL2095231 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3069964 | |
| PharmGKB | PA166163410 | |
| DrugBank | DB09297 | |
| PubChem: Thomson Pharma | 92299426 | |
| PubChem | 45110509 | |
| Nikkaji | J3.361.353I | |
| DrugCentral | 4913 | |
| ChemicalBook | CB22748429 | CB72677412 |
| Guide to Pharmacology | 11273 | |
| rxnorm | PARITAPREVIR | |
| ZINC | ZINC000197964623 |
